◀ Back to CCND1
CCND1 — CDK1
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *
Text-mined interactions from Literome
Chang et al., Int J Oncol 2000
(Neoplasms, Experimental) :
Inhibition of
cyclin D1 expression or
induction of
cyclin dependent kinase inhibitor p21WAF1 expression was found in mimosine treated lung cancer cells
Osborne et al., Br J Dermatol 2002
(Breast Neoplasms...) :
1,25 ( OH ) 2D3 has a major inhibitory effect on the G1/S checkpoint of the cell cycle by upregulating the
cyclin dependent kinase inhibitors p27 and p21, and by
inhibiting cyclin D1
Cheng et al., Cancer Sci 2004
(Carcinoma, Hepatocellular...) :
Etodolac induced p21WAF1/Cip1 and p27Kip1 expression and
inhibited CDK2, CDK4,
CDC2 , cyclin A and cyclin B1 expression, but did not affect
cyclin D1 or cyclin E. HGF and 10 % FBS induced ERK phosphorylation, but phosphorylation of p38, JNK and AKT was down-regulated by etodolac
Nelsen et al., J Biol Chem 2005
(Aneuploidy...) :
Transient transfection of
cyclin D1 also
induced centrosome and mitotic spindle abnormalities in breast epithelial cells, suggesting that this may be a generalized effect
Lavine et al., Mol Endocrinol 2008
:
Analysis of cyclin and cdk mRNA and protein abundance revealed that CCK overexpression
increased cyclin A, cyclin B, cyclin E,
cdk1 , and cdk2 with no change in
cyclin D1 , cyclin D2, cyclin D3, cdk4, or cdk6 in mouse and human islets
Brennan et al., J Med Food 2012
(Adrenocortical Carcinoma) :
BME treatment enhanced cellular tumor antigen p53,
cyclin dependent kinase inhibitor 1A ( also called p21 ), and cyclic AMP dependent transcription factor-3 levels and
inhibited G1/S-specific cyclin D1 , D2, and D3, and mitogen activated protein kinase 8 ( also called Janus kinase ) expression, suggesting an additional mechanism involving cell cycle regulation and cell survival
Kang et al., Apoptosis 2012
:
Cell cycle analysis indicated thioridazine induced the down-regulation of
cyclin D1 , cyclin A and CDK4, and the induction of p21 and p27, a
cyclin dependent kinase inhibitor